Personalized Management of Anastomotic Leak after Surgery for Esophageal Carcinoma

作     者：Hong-yu Ye Wei-zhao Huang Yin-meng Wu Yi Liang Jun-meng Zheng Hai-ming Jiang 

作者机构：Department of Cardio-thoracic SurgeryZhongshan Hospital of Sun Yat-sen University(Zhongshan People's Hospital)Zhongshan 528403China 

出 版 物：《Chinese Medical Sciences Journal》 (中国医学科学杂志（英文版）)

年 卷 期：2012年第27卷第1期

页      面：35-40页

核心收录：

学科分类：090603[农学-临床兽医学] 120202[管理学-企业管理（含：财务管理、市场营销、人力资源管理）] 12[管理学] 1202[管理学-工商管理] 09[农学] 0906[农学-兽医学] 

主　　题：esophageal surgery anastomotic leak resurgery stent 

摘      要：Objective To summarize the management of anastomotic leak following surgery for esophageal car-cinoma. Methods The medical records of the patients developing digestive tract leak after surgery for esophageal carcinoma in our hospital from January 2003 to March 2011 were retrospectively analyzed. Results A total of 36 patients were included, in whom 13 developed cervical anastomotic leak, 18 had intra-thoracic anastomotic leak, and 5 had intra-thoracic gastric necrosis. Of these patients, 7 were treated with resurgery, 6 with esophageal stent implantation, and 23 with conservative treatment. Treatment lasted for 5 to 181 days, averagely 47.0±31.9 days. After management, 9 patients died (25.0%). Among seven patients with resurgery, four had deceased, two were cured, and one developed leak again and was switched to conservative treatment until discharged. All the 6 patients treated with stent implantation were cured. Of the 24 patients receiving conservative treatment (including one switched from resurgery), 18 (75.0%) were cured and 1 was not cured but survived. Conclusions Anastomotic leak following surgery for esophageal carcinoma should be treated individually based on the onset time, location, size, and extent of the leakage. Conservative treatment is still a safe and effective *** efficacy of stent implantation needs further investigation to confirm.